Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

BACKGROUND: Indirect evidence suggesting the immunosensitivity/immunogenicity of neuroblastoma is accumulating. The aims of this study were to investigate the immune landscape of neuroblastoma and to evaluate the in vivo immunogenicity of the NY-ESO-1 tumor antigen in advanced neuroblastoma patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Camisaschi, Chiara, Renne, Salvatore Lorenzo, Beretta, Valeria, Rini, Francesca, Spagnuolo, Rosalin Dolores, Tuccitto, Alessandra, Podda, Marta Giorgia, Parmiani, Giorgio, Rivoltini, Licia, Collini, Paola, Castelli, Chiara, Luksch, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192300/
https://www.ncbi.nlm.nih.gov/pubmed/30326856
http://dx.doi.org/10.1186/s12885-018-4910-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192300/
https://www.ncbi.nlm.nih.gov/pubmed/30326856
http://dx.doi.org/10.1186/s12885-018-4910-8

Ejemplares similares